Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Stage-related transcriptional changes in HR-positive/HER2-negative breast cancer.

NPJ breast cancer·2026

Same author

Glioma region-specific metabolites associated with patient seizures.

Journal of neuro-oncology·2026

Same author

Sensitivity to endocrine therapy index predicts benefit from weekly adjuvant paclitaxel for hormone receptor-positive breast cancer in the GEICAM/9906 trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Same author

TRAMFIX: TRavelling Across Melbourne for FIXel-based analysis (a reproducibility and reliability study).

Imaging neuroscience (Cambridge, Mass.)·2026

Same author

Longitudinal quantitative streamline tractography: robust estimation of white matter connectivity differences.

bioRxiv : the preprint server for biology·2026

Same author

Clinical Staging Versus Biomarker-Guided Initiation of Continuous Renal Replacement Therapy: A Systematic Review and Meta-Analysis.

Cureus·2026

Same journal

Discovery of Phytochemicals as Inhibitors of Human Metapneumovirus: In-Silico Docking Studies.

Current drug discovery technologies·2026

Same journal

From Molecules to Manufacturing: Expanding Role of Artificial Intelligence in Pharmaceutical Sciences.

Current drug discovery technologies·2026

Same journal

Targeting Biofilm Formation in Acinetobacter baumannii: In Silico Discovery of Novel Candidate Inhibitors for Acyl-Homoserine Lactone Synthase.

Current drug discovery technologies·2026

Same journal

Effects of Ganoderma lucidum Polysaccharide Peptide on Inflammatory and Metabolic Biomarkers in Obese Patients with Cardiometabolic Syndrome: A Randomized Controlled Trial.

Current drug discovery technologies·2026

Same journal

Using Computational Intelligence to Connect Data and Drug Design in Medicinal Chemistry: A Review.

Current drug discovery technologies·2026

Same journal

Uncovering the Anti-Pleurisy Mechanism of Shizao Decoction via Network Pharmacology and Molecular Docking.

Current drug discovery technologies·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 13, 2026

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Network medicine and high throughput screening.

Robert E Smith¹, Kevin Tran, Ralph H Vocque

¹Total Diet and Pesticide Research Center, U.S. Food and Drug Administration, Lenexa, KS 66214, USA. robert.smith@fda.hhs.gov

Current Drug Discovery Technologies

|March 26, 2013

Summary

This summary is machine-generated.

Network medicine combined with high throughput screening (HTS) offers a new drug discovery approach. This fusion integrates biological systems with advanced assays to develop effective drugs with fewer side effects.

More Related Videos

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Related Experiment Videos

Last Updated: May 13, 2026

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Area of Science:

Systems Biology
Pharmacology
Computational Biology

Background:

Modern drug discovery is evolving, integrating traditional and modern medicine.
A new paradigm fuses phenotypic and targeted approaches, and systems with reductionist thinking.
Network medicine and high throughput screening (HTS) exemplify this fusion, combining physiologically relevant biological systems with robust assay technologies.

Purpose of the Study:

To describe the principles of network theory and network medicine tools.
To discuss scale-free networks and their emergent properties in biological systems.
To highlight the application of modern HTS and high content screening (HCS) in complex biological networks.

Main Methods:

Utilizing network theory and network medicine principles.
Constructing databases from multi-omics data (metabolome, genome, transcriptome, proteome, etc.).
Employing high throughput screening (HTS) and high content screening (HCS) to analyze biological network interactions and perturbations.

Main Results:

Network medicine provides tools to understand complex biological systems as networks.
HTS and HCS enable the examination of interactions within the human biological network.
Allo-network drugs can exert effects beyond single targets, impacting cellular communication.

Conclusions:

This integrated approach reveals hidden connections within biological networks.
The goal is to develop novel drugs with minimal side effects.
This strategy aims to create effective treatments for challenging conditions like multi-drug resistant cancers and bacteria.